tiprankstipranks
Trending News
More News >
Guard Therapeutics International AB (SE:GUARD)
:GUARD
Advertisement

Guard Therapeutics International AB (GUARD) Price & Analysis

Compare
0 Followers

GUARD Stock Chart & Stats


GUARD FAQ

What was Guard Therapeutics International AB’s price range in the past 12 months?
Guard Therapeutics International AB lowest stock price was kr11.85 and its highest was kr33.37 in the past 12 months.
    What is Guard Therapeutics International AB’s market cap?
    Guard Therapeutics International AB’s market cap is kr465.87M.
      When is Guard Therapeutics International AB’s upcoming earnings report date?
      Guard Therapeutics International AB’s upcoming earnings report date is Aug 21, 2025 which is 2 days ago.
        How were Guard Therapeutics International AB’s earnings last quarter?
        Currently, no data Available
        Is Guard Therapeutics International AB overvalued?
        According to Wall Street analysts Guard Therapeutics International AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Guard Therapeutics International AB pay dividends?
          Guard Therapeutics International AB does not currently pay dividends.
          What is Guard Therapeutics International AB’s EPS estimate?
          Guard Therapeutics International AB’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Guard Therapeutics International AB have?
          Guard Therapeutics International AB has 20,167,631 shares outstanding.
            What happened to Guard Therapeutics International AB’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Guard Therapeutics International AB?
            Currently, no hedge funds are holding shares in SE:GUARD

            Company Description

            Guard Therapeutics International AB

            Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.

            Guard Therapeutics International AB (GUARD) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Xbrane Biopharma AB
            Ascelia Pharma AB
            Intervacc AB
            Immunicum AB
            Corline Biomedical AB
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis